March 25, 2026 Sweden
Presentation of the Quarterly Report 2 2025/2026
Diamyd Medical’s CEO Ulf Hannelius and CFO Niklas Axelsson present the company’s quarterly report and provide an update on the current status of the business.
The report was published on March 25, 2026. Produced in collaboration with BioStock, moderated by Cecilia Hallström.
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.